En muchos casos pueden estar lesionadas sin poder hacer ejercicio, con perfil proinflamatorio, sueo deficiente, hinchazn permanente, niebla mental, olvidos frecuentes y, a menudo, prediabetes incipiente no diagnosticada
We remain steadfast in our mission to harness the pharmaceutical potential of ketamine for a range of mental health, neurological, and pain disorders. - Fabio Chianelli, founder, chairman, and CEO of PharmaTher You can read more about the approval here
The related Athira compound fosgonimeton failed its Phase 2 Alzheimer's trial (LIFT-AD) in 2023 for efficacy, and Athira discontinued development
Cell 128 (4), 693705
Control of sulfur partitioning between primary and secondary metabolism in Arabidopsis